Similar articles

• The clinical spectrum and pathogenesis of HIV encephalopathy, myelopathy, and peripheral neuropathy.

  Brew BJ. Brew BJ. Curr Opin Neurol. 1994 Jun;7(3):209-16. doi: 10.1097/00019052-199406000-00006. Curr Opin Neurol. 1994. PMID: 8081514 Review.
• Unifying hypothesis for the pathogenesis of HIV-associated dementia complex, vacuolar myelopathy, and sensory neuropathy.

  Tyor WR, Wesselingh SL, Griffin JW, McArthur JC, Griffin DE. Tyor WR, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Aug 1;9(4):379-88. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 7600105 Review.
• Abnormalities in cholesterol metabolism cause peripheral neuropathy and dementia in AIDS--a hypothesis.

  Falkenbach A, Klauke S, Althoff PH. Falkenbach A, et al. Med Hypotheses. 1990 Sep;33(1):57-61. doi: 10.1016/0306-9877(90)90085-s. Med Hypotheses. 1990. PMID: 2175010
• Hypothesis on the pathogenesis of vacuolar myelopathy, dementia, and peripheral neuropathy in AIDS.

  Tan SV, Guiloff RJ. Tan SV, et al. J Neurol Neurosurg Psychiatry. 1998 Jul;65(1):23-8. doi: 10.1136/jnnp.65.1.23. J Neurol Neurosurg Psychiatry. 1998. PMID: 9667556 Free PMC article. Review.
• The pathogenesis of the neurological complications of HIV-1 infection.

  Brew BJ. Brew BJ. Genitourin Med. 1993 Oct;69(5):333-40. doi: 10.1136/sti.69.5.333. Genitourin Med. 1993. PMID: 8244348 Free PMC article. Review. No abstract available.